Development of Vasoinhibin-Specific Monoclonal Antibodies

Development of Vasoinhibin-Specific Monoclonal Antibodies

Vasoinhibin is a protein hormone with antiangiogenic, antivasodilatatory, and antivasopermeability effects generated by the proteolytic cleavage of prolactin. The discovery of its role in diabetic retinopathy and peripartum cardiomyopathy led to the evaluation of new pharmacological treatments in cl...

Full description

Bibliographic Details
Main Authors: Nils Müller, Juan Pablo Robles, Magdalena Zamora, Johannes Ebnet, Hülya Markl-Hahn, Gonzalo Martínez de la Escalera, Carmen Clapp, Thomas Bertsch, Jakob Triebel
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Endocrinology
Subjects:
vasoinhibin
prolactin (PRL)
monoclonal antibodies
16K PRL
ELISA - enzyme-linked immunosorbent assay
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.645085/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.645085/full

Similar Items